Jégo G - Search Results

1

TLR9 ligand induces the generation of CD20+ plasmablasts and plasma cells from CD27+ memory B-cells.

Geffroy-Luseau A, Chiron D, Descamps G, Jégo G, Amiot M, Pellat-Deceunynck C. Geffroy-Luseau A, et al. Among authors: jego g. Front Immunol. 2011 Dec 30;2:83. doi: 10.3389/fimmu.2011.00083. eCollection 2011. Front Immunol. 2011. PMID: 22566872 Free PMC article.

2

Osteoclasts support the survival of human plasma cells in vitro.

Geffroy-Luseau A, Jégo G, Bataille R, Campion L, Pellat-Deceunynck C. Geffroy-Luseau A, et al. Among authors: jego g. Int Immunol. 2008 Jun;20(6):775-82. doi: 10.1093/intimm/dxn035. Epub 2008 Apr 8. Int Immunol. 2008. PMID: 18397910

3

TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production.

Chiron D, Pellat-Deceunynck C, Amiot M, Bataille R, Jego G. Chiron D, et al. Among authors: jego g. J Immunol. 2009 Apr 1;182(7):4471-8. doi: 10.4049/jimmunol.0803113. J Immunol. 2009. PMID: 19299748

4

The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy.

Bataille R, Jégo G, Robillard N, Barillé-Nion S, Harousseau JL, Moreau P, Amiot M, Pellat-Deceunynck C. Bataille R, et al. Among authors: jego g. Haematologica. 2006 Sep;91(9):1234-40. Haematologica. 2006. PMID: 16956823 Review.

5

Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis.

Chiron D, Pellat-Deceunynck C, Maillasson M, Bataille R, Jego G. Chiron D, et al. Among authors: jego g. J Immunol. 2009 Oct 1;183(7):4371-7. doi: 10.4049/jimmunol.0901436. Epub 2009 Sep 4. J Immunol. 2009. PMID: 19734228

6

Modulation of normal and malignant plasma cells function by toll-like receptors.

Jego G, Chiron D, Berthenet K, Pellat-Deceunynck C. Jego G, et al. Front Biosci (Elite Ed). 2012 Jan 1;4(6):2289-301. doi: 10.2741/e542. Front Biosci (Elite Ed). 2012. PMID: 22202037 Free article. Review.

7

Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells.

Jego G, Robillard N, Puthier D, Amiot M, Accard F, Pineau D, Harousseau JL, Bataille R, Pellat-Deceunynck C. Jego G, et al. Blood. 1999 Jul 15;94(2):701-12. Blood. 1999. PMID: 10397737 Free article.

8

Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors.

Jego G, Bataille R, Geffroy-Luseau A, Descamps G, Pellat-Deceunynck C. Jego G, et al. Leukemia. 2006 Jun;20(6):1130-7. doi: 10.1038/sj.leu.2404226. Leukemia. 2006. PMID: 16628189

9

Toll-like receptors: lessons to learn from normal and malignant human B cells.

Chiron D, Bekeredjian-Ding I, Pellat-Deceunynck C, Bataille R, Jego G. Chiron D, et al. Among authors: jego g. Blood. 2008 Sep 15;112(6):2205-13. doi: 10.1182/blood-2008-02-140673. Epub 2008 Jun 30. Blood. 2008. PMID: 18591383 Free PMC article. Review.

10

Toll-like receptors: expression and involvement in multiple myeloma.

Chiron D, Jego G, Pellat-Deuceunynck C. Chiron D, et al. Among authors: jego g. Leuk Res. 2010 Dec;34(12):1545-50. doi: 10.1016/j.leukres.2010.06.002. Epub 2010 Jul 1. Leuk Res. 2010. PMID: 20594595 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters